Skip to main content
. 2020 Jul 29;21(15):5386. doi: 10.3390/ijms21155386
AIM Absence in melanoma 2
ALRs Absence in melanoma 2-like receptors
AP Acute pancreatitis
ASC Caspase recruitment domain
CAPS Cryopyrin-associated periodic syndrome
CARD Caspase activation and recruitment domain
CARS Compensatory anti-inflammatory response syndrome
CLRs C-type lectin receptors
COX-2 Cyclo-oxygenase-2
DAMPs Damage-Associated Molecular Patterns
GSDM-D Gasdermin-D
HMGB1 High mobility group box 1
IL Interleukin
IL1R Interleukin 1 receptor
IRAK IL1R-associated kinase
IRF Interferon regulatory factor
LPS Lipopolysaccharide
MAPK Mitogen-activated protein kinase
MyD88 Myeloid differentiation primary response 88
NATCH Nucleotide-binding and oligomerization domain
NF-κB Nuclear factor-kappa B
NLRP3 NLR pyrin domain containing protein 3
NOD1 NLR nucleotide-binding oligomerization domain-containing protein 1
Nrf2 Nuclear factor erythrocyte-2 associated factor 2
NSAIDS Non-steroidal anti-inflammatory drugs
PAMPs Pathogen-Associated Molecular Patterns
PRR Pattern recognition receptors
PYD Pyrin domain
RAGE Receptor for advanced glycation end-products
RLRs Retinoic acid-inducible gene (RIG)-I-like receptors
ROS Reactive oxygen species
SIRS Systemic inflammatory response syndrome
TLR Toll-like receptor
TNFα Tumor necrosis factor alpha
TRAF Tumor necrosis factor receptor-activated factor
TRIF TIR-domain-containing adaptor molecule inducing interferon-beta